The Medicines and Healthcare products Regulatory Agency approves the use of antibody-based treatment to preventing infections in adults with poor immune response Evushield developed by AstraZeneca. (Reuters) COVID-19 pandemic in the United Kingdom, COVID-19 drug developmentCOVID-19 pandemic link embed save